Review · Nutrients · 2021Conflicts declared

Creatine, blood sugar and diabetes: what the evidence shows

What it found

Creatine may help blood sugar control, especially when combined with exercise, but the authors say the evidence is still speculative and based on small, short studies.

What they found

Studies in people

Creatine alone in people

In healthy people, creatine alone had mixed effects on blood sugar and glycogen. One small study in type 2 diabetes patients found creatine was as effective as metformin at lowering blood sugar, but other studies found no change in insulin sensitivity.

Creatine plus exercise in people

A small trial in type 2 diabetes patients found that creatine with exercise training reduced glycated hemoglobin and blood sugar after a meal. But a later trial in older adults found no improvement in insulin resistance.

Muscle glucose transport

Creatine plus exercise increased a key protein that moves glucose into muscle cells in some human studies. This may help explain the blood sugar improvements seen when the two are combined.

Animal and lab studies

Blood sugar in animals

In some animal models, creatine improved blood sugar and insulin sensitivity, but in others it made hyperglycemia worse. The authors say these conflicting results are hard to interpret because responses vary by species and model.

Studies in people and animals

Insulin secretion in lab tests

In lab tests, creatine stimulated insulin secretion from isolated rat pancreas, mouse islets and insulinoma cells. But human studies in healthy and type 2 diabetes adults did not show increased insulin secretion.

What the authors conclude

“Although preliminary findings from small-scale trials involving patients with type 2 diabetes mellitus are promising, the efficacy of creatine for improving glycemic control is yet to be confirmed.”
Solis MY, Artioli GG, Gualano B, 2021

Also in their conclusions

  • They say creatine supplementation has the potential to promote changes in glucose metabolism that may favor a healthier metabolic profile, especially when exercise training is provided along with it.
  • They state that evidence supporting the role of creatine on glucose metabolism remains speculative and that further large, longer-term, controlled trials are necessary to draw firm conclusions on the efficacy and safety of creatine as an anti-diabetic intervention.
  • They advise that new investigations are needed to unravel the mechanisms by which creatine, with or without training, could regulate glucose control.

How it was done

The authors wanted to explore whether creatine supplementation could help manage blood sugar and be a potential anti-diabetic intervention, given the growing burden of type 2 diabetes and preliminary evidence from animal and human studies.

They reviewed existing studies on creatine supplementation and glucose metabolism, including animal experiments and human trials, some with exercise training, in healthy people, insulin-resistant people and those with type 2 diabetes.

What it can’t tell you

  • Most of the human trials were small and short, so they cannot show whether creatine works over the long term or in different groups of people with diabetes.
  • The animal results cannot be directly applied to people because creatine responses vary greatly between species and experimental models.
  • The review cannot confirm whether creatine is safe or effective as a diabetes treatment because the evidence is still preliminary.

The paper

Title
Potential of Creatine in Glucose Management and Diabetes
Type
ReviewThe authors read earlier studies and describe what they found. It isn’t a new study.
Evidence
Studies in people · animals · lab
Summarised from
Full text
Licence
CC BY. Words in quotation marks are the authors’; the rest is our summary.
Cite
Solis MY, Artioli GG, Gualano B (2021). Potential of Creatine in Glucose Management and Diabetes. Nutrients. doi:10.3390/nu13020570Free full textPubMed 33572228DOI

Summary written 29 Sep 2026. Check it against the paper before it changes what you eat. How we summarise papers · Report an error